drugset / Trial / NCT01825473

Study of Erythromycin in GER-Associated Apnea of the Newborn

NCT01825473

Unknown 40 enrolled University of Virginia
RandomizedParallel-groupTriple-blindTreatment

Summary

To evaluate the relationship of reflux and apnea and to determine whether the administration of erythromycin improves the incidence of GER and GER-associated apnea, bradycardic and/or desaturation events in a prospective randomized controlled trial.

Timeline

Start
2012-09
Primary completion
2014-03
Completion
2014-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Erythromycin Small molecule 50 mg/kg Oral